Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin

Journal of Infection and Chemotherapy

Volumn 18, Issue 6, 2012, Pages 958-960

  Mellon, Guillaume ^a   Clec'H, Christophe ^a   Picard, Bertrand ^a,b,c   Cohen, Yves ^a   Jauréguy, Françoise ^a,b,c  

^a AVICENNE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

Acinetobacter baumannii; Ampicillin sulbactam; Fosfomycin; Multiresistant; Rifampicin

Indexed keywords

AMIKACIN; CEFEPIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GLUCOSE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; SULBACTAM;

ABSENCE OF SIDE EFFECTS; ACINETOBACTER INFECTION; ADULT; AEROMONAS HYDROPHILA; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BRAIN CONTUSION; BRAIN HEMATOMA; BRAIN RADIOGRAPHY; CASE REPORT; CERVICAL SPINE INJURY; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DISEASE SEVERITY; DRUG MEGADOSE; ELBOW INJURY; ENTEROBACTER CLOACAE; GLUCOSE BRAIN LEVEL; HEAD INJURY; HUMAN; INTERVERTEBRAL DISKECTOMY; LAMINECTOMY; LIQUORRHEA; LYMPHOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUROLOGIC EXAMINATION; NEUTROPHIL COUNT; OSTEOSYNTHESIS; OUTCOME ASSESSMENT; PROTEIN CEREBROSPINAL FLUID LEVEL; PSEUDOMONAS FLUORESCENS; QUADRIPLEGIA; TREATMENT DURATION; ACINETOBACTER BAUMANNII; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; POSTOPERATIVE COMPLICATION; TRAFFIC ACCIDENT;

ACCIDENTS, TRAFFIC; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AMPICILLIN; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FOSFOMYCIN; HUMANS; MALE; MENINGITIS, BACTERIAL; POSTOPERATIVE COMPLICATIONS; RIFAMPIN; SULBACTAM;

EID: 84880404980     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0404-9     Document Type: Article

References (12)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148-65. (Pubitemid 26123943)
2. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21-8. (Pubitemid 23011467)
3. Seifert H, Richter W, Pulverer G. Clinical and bacteriological features of relapsing shunt-associated meningitis due to Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 1995;14:130-4.
4. Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis. 2009;9:245-55.
5. Jimenez-Mejias ME, Pachon J, Becerril B, Palomino-Nicas J, Rodriguez-Cobacho A, Revuelta M. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam. Clin Infect Dis. 1997;24:932-5. (Pubitemid 27193880)
6. Cawley MJ, Suh C, Lee S, Ackerman BH. Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis. Pharmacotherapy. 2002;22:527-32. (Pubitemid 34270038)
7. Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, et al. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1998;42:793-802. (Pubitemid 29008082)
8. Murray PR, Cantrell HF, Lankford RB. Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveillance Group. Diagn Microbiol Infect Dis. 1994;19:111-20.
9. Jones RN, Dudley MN. Microbiologic and pharmacodynamic principles applied to the antimicrobial susceptibility testing of ampicillin/sulbactam: analysis of the correlations between in vitro test results and clinical response. Diagn Microbiol Infect Dis. 1997;28:5-18. (Pubitemid 27314865)
10. Pachon-Ibanez ME, Docobo-Perez F, Lopez-Rojas R, Dominguez-Herrera J, Jimenez-Mejias ME, Garcia-Curiel A, et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2010;54:1165-72.
11. Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents. 2009;34:111-20.
12. Martinez-Martinez L, Rodriguez G, Pascual A, Suarez AI, Perea EJ. In vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii. J Antimicrob Chemother. 1996;38:1107-8. (Pubitemid 27073294)